pmc logo imageJournal ListSearchpmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site
Infect Immun. 1983 February; 39(2): 823–829.
PMCID: PMC348023
Delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice is enhanced by dextran sulfate.
M Kishima, C Kuniyasu, and M Nakagawa
Abstract
The enhancing effect of dextran sulfate (DS) on delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice was evaluated by means of delayed footpad swelling. Mice pretreated subcutaneously with nonviable M. pulmonis and DS had significantly increased delayed footpad swelling when the mice were injected subcutaneously in the footpad with the same antigen 7 days later. Delayed footpad swelling was not detected in mice pretreated only with nonviable M. pulmonis or DS followed by footpad injection with nonviable M. pulmonis. Subcutaneous pretreatment in the scruff of the neck with nonviable M. pulmonis and DS was more effective in eliciting delayed footpad swelling than intravenous or intraperitoneal pretreatment. Delayed footpad swelling did not develop when mice were injected in the footpad with nonviable Mycoplasma hyopneumoniae, M. gallisepticum, M. dispar, or M. bovis on day 7 after pretreatment with M. pulmonis and DS. Injection of nonviable M. pulmonis in the footpad on day 3 after pretreatment with M. pulmonis and DS resulted in no significant footpad swelling, but injection in the footpad on days 7, 14, 21, and 28 resulted in significant footpad swelling. Delayed footpad swelling was transferred by intravenous injection with spleen cells of mice which were pretreated with nonviable M. pulmonis and DS into nontreated recipient mice. Intravenous injection with anti-mouse thymus cell rabbit serum into the mice which were previously pretreated with nonviable M. pulmonis and DS reduced the delayed footpad swelling significantly.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (988K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Adegboye, DS. Attempts to demonstrate cell-mediated immune response during Mycoplasma suipneumoniae infection of pigs. Res Vet Sci. 1978 Nov;25(3):323–330. [PubMed]
  • Arai, S; Hinuma, Y; Matsumoto, K; Nakamura, T. Delayed type hypersensitivity in hamsters infected with Mycoplasma pneumoniae as revealed by macrophage migration inhibition test. Jpn J Microbiol. 1971 Nov;15(6):509–514. [PubMed]
  • Atobe, H; Ogata, M. Pneumonitis in mice inoculated with Mycoplasma pulmonis: production of pulmonary lessions and persistence of organisms and antibodies. Nippon Juigaku Zasshi. 1974 Dec;36(6):495–503. [PubMed]
  • Babcock, GF; McCarthy, RE. Suppression of cell-mediated immune responses by dextran sulphate. Immunology. 1977 Dec;33(6):925–929. [PubMed]
  • Bennett, RH; Carroll, EJ; Jasper, DE. Skin-sensitivity reactions in calves inoculated with Mycoplasma bovis antigens: humoral and cell-mediated responses. Am J Vet Res. 1977 Nov;38(11):1721–1730. [PubMed]
  • Ben-Sasson, SA; Henkart, PA. Enhancement of weak mixed lymphocyte-type reactions by hydrophilic polymers. J Immunol. 1977 Jul;119(1):227–231. [PubMed]
  • Biberfeld, G. Cell-mediated immune response following Mycoplasma pneumoniae infection in man. II. Leucocyte migration inhibition. Clin Exp Immunol. 1974 May;17(1):43–49. [PubMed]
  • Biberfeld, G; Biberfeld, P; Sterner, G. Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation. Clin Exp Immunol. 1974 May;17(1):29–41. [PubMed]
  • Brennan, PC; Fritz, TE; Flynn, RJ. Role of Pasteurella pneumotropica and Mycoplasma pulmonis in murine pneumonia. J Bacteriol. 1969 Jan;97(1):337–349. [PubMed]
  • Cole, BC; Golightly-Rowland, L; Ward, JR. Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice. Infect Immun. 1975 Nov;12(5):1083–1092. [PubMed]
  • Denny, FW; Taylor-Robinson, D; Allison, AC. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol. 1972 Aug;5(3):327–336. [PubMed]
  • Fernald, GW. In vitro response of human lymphocytes to Mycoplasma pneumoniae. Infect Immun. 1972 Apr;5(4):552–558. [PubMed]
  • Ginsburg, H; Nicolet, J. Extensive transformation of lymphocytes by a mycoplasma organism. Nat New Biol. 1973 Dec 5;246(153):143–146. [PubMed]
  • Hahn, H. Effects of Dextran Sulfate 500 on Cell-Mediated Resistance to Infection with Listeria monocytogenes in Mice. Infect Immun. 1974 Nov;10(5):1105–1109. [PubMed]
  • Hahn, Helmut; Bierther, Manfred. Morphological Changes Induced by Dextran Sulfate 500 in Mononuclear Phagocytes of Listeria-Infected Mice. Infect Immun. 1974 Nov;10(5):1110–1119. [PubMed]
  • Kristensen, B; Paroz, P; Nicolet, J; Wanner, M; de Weck, AL. Cell-mediated and humoral immune response in swine after vaccination and natural infection with Mycoplasma hyopneumoniae. Am J Vet Res. 1981 May;42(5):784–788. [PubMed]
  • Lindsey, JR; Cassell, H. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol. 1973 Jul;72(1):63–90. [PubMed]
  • Lutsky, II; Organick, AB. Pneumonia due to mycoplasma in gnotobiotic mice. I. Pathogenicity of Mycoplasma pneumoniae, Mycoplasma salivarium, and Mycoplasma pulmonis for the lungs of conventional and gnotobiotic mice. J Bacteriol. 1966 Oct;92(4):1154–1163. [PubMed]
  • McCarthy, RE; Arnold, LW; Babcock, GF. Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology. 1977 Jun;32(6):963–974. [PubMed]
  • McCarthy, RE; Babcock, GF. Simultaneous stimulation and suppression of two different indicators of the cell-mediated immune response by the immunoregulator dextran sulphate. Immunology. 1978 May;34(5):927–929. [PubMed]
  • Naot, Y; Davidson, S; Lindenbaum, ES. Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic myeoplasmal membranes. J Infect Dis. 1981 Jan;143(1):55–62. [PubMed]
  • Naot, Y; Tully, JG; Ginsburg, H. Lymphocyte activation by various Mycoplasma strains and species. Infect Immun. 1977 Nov;18(2):310–317. [PubMed]
  • Roberts, DH. Preliminary studies on the cell-mediated immune response in pigs to Mycoplasma hyopneumoniae. Br Vet J. 1973 129(5):427–438.Sep–Oct; [PubMed]
  • Saito, M; Nakagawa, M; Muto, T; Imaizumi, K. Strain difference of mouse in susceptibility to Mycoplasma pulmonis infection. Nippon Juigaku Zasshi. 1978 Dec;40(6):697–705. [PubMed]
  • Taylor, G; Taylor-Robinson, D; Fernald, GW. Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J Med Microbiol. 1974 Aug;7(3):343–348. [PubMed]
  • Timms, L; Cullen, GA. Cell-mediated and humoral immune response of chickens to Mycoplasma synoviae. Avian Dis. 1976 20(1):96–107.Jan–Mar; [PubMed]
  • Wittmann, G. The effect of DEAE dextran, dextran sulfate and dextran on porcine mixed lymphocyte reaction. Zentralbl Veterinarmed B. 1979 Aug;26(6):479–491. [PubMed]
  • Yoshikai, Y; Miake, S; Matsumoto, T; Nomoto, K; Takeya, K. Effect of stimulation and blockade of mononuclear phagocyte system on the delayed footpad reaction to SRBC in mice. Immunology. 1979 Nov;38(3):577–583. [PubMed]